Document

FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in

ICR 201709-0910-002 · OMB 0910-0847 · Object 84026501.

Document Viewer [pdf]

Status: Original and derived artifacts are available for this document.

Download: pdf

Primary: pdfSource: application/octet-stream
Loading document viewer…
Document Metadata
File Typeapplication/octet-stream
File TitleFDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in
Subject2
AuthorFDA/CDER
File Modified2018-06-13
File Created2018-02-22
Conversion Statecomplete